BillionToOne BLLN
$89.92 −$0.28 (-0.31%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $89.92 0.00%
Open$88.80
Prev close$90.20
Day range$88.00 – $91.43
Volume819.5K
Market cap$4.30B
P/E (TTM)93.2
Dividend yield–
BLLN Stock News
Headlines matching BillionToOne or the BLLN ticker, most recent first.
- BillionToOne(BLLN.US) Officer Sells US$3.87 Million in Common Stock
- CCORF Initiates BillionToOne(BLLN.US) With Buy Rating, Announces Target Price $120
- Form 144 | BillionToOne(BLLN.US) Officer Proposes to Sell 3.87 Million in Common Stocks
- BillionToOne(BLLN.US) Officer Sells US$3.03 Million in Common Stock
- Analysts Offer Insights on NA Companies: BillionToOne, Inc. Class A (BLLN) and MBX Biosciences, Inc. (MBX)
- William Blair Initiates BillionToOne(BLLN.US) With Buy Rating
- Analysts Are Bullish on These NA Stocks: BillionToOne, Inc. Class A (BLLN), Carlsmed, Inc. (CARL) Positive
- BTIG Maintains BillionToOne(BLLN.US) With Buy Rating, Raises Target Price to $142 Positive
- J.P. Morgan Maintains BillionToOne(BLLN.US) With Buy Rating, Raises Target Price to $145 Positive
- Guggenheim Maintains BillionToOne(BLLN.US) With Buy Rating, Raises Target Price to $125 Positive
- Analysts Have Conflicting Sentiments on These Healthcare Companies: BillionToOne, Inc. Class A (BLLN) and Bio-Techne (TECH)
- Analysts Offer Insights on Healthcare Companies: BillionToOne, Inc. Class A (BLLN), ACADIA Pharmaceuticals (ACAD) and Revolution Medicines (RVMD)
- Piper Sandler Maintains BillionToOne(BLLN.US) With Buy Rating, Cuts Target Price to $130 Negative
- A Quick Look at Today's Ratings for BillionToOne(BLLN.US), With a Forecast Between $100 to $145
- Stifel Nicolaus Keeps Their Buy Rating on BillionToOne, Inc. Class A (BLLN)
No comments yet — be the first to weigh in on BLLN.
Sign in to join the discussion.